Evidence map›Paper›PMID 38257789›Full record

ArticleViruses2024

UV-C Light Intervention as a Barrier against Airborne Transmission of SARS-CoV-2.

Izabela Ragan, Jessie Perez, Wilson Davenport, Lindsay Hartson, Branden Doyle

Open access · goldAbstract read
In one paragraph

Article in Viruses, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.4field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Izabela RaganDepartment of Biomedical Science, Colorado State University, Fort Collins, CO 80521, USA.ORCID 0000-0002-1379-6015
Jessie PerezViolett Inc., Gig Harbor, WA 98332, USA.
Wilson DavenportViolett Inc., Gig Harbor, WA 98332, USA.ORCID 0009-0007-6435-6734
Lindsay HartsonDepartment of Microbiology, Immunology & Pathology, Colorado State University, Fort Collins, CO 80521, USA.ORCID 0000-0002-3131-3507
Branden DoyleViolett Inc., Gig Harbor, WA 98332, USA.
Colorado State University · US

Funding

Colorado State University N/A
6 · The paper itself

Abstract

backgroundSARS-CoV-2 continues to impact human health globally, with airborne transmission being a significant mode of transmission. In addition to tools like vaccination and testing, countermeasures that reduce viral spread in indoor settings are critical. This study aims to assess the efficacy of UV-C light, utilizing the Violett sterilization device, as a countermeasure against airborne transmission of SARS-CoV-2 in the highly susceptible Golden Syrian hamster model.

methodsTwo cohorts of naïve hamsters were subjected to airborne transmission from experimentally infected hamsters; one cohort was exposed to air treated with UV-C sterilization, while the other cohort was exposed to untreated air.

resultsTreatment of air with UV-C light prevented the airborne transmission of SARS-CoV-2 from the experimentally exposed hamster to naïve hamsters. Notably, this protection was sustained over a multi-day exposure period during peak viral shedding by hamsters.

conclusionsThese findings demonstrate the efficacy of the UV-C light to mitigate against airborne SARS-CoV-2 transmission. As variants continue to emerge, UV-C light holds promise as a tool for reducing infections in diverse indoor settings, ranging from healthcare facilities to households. This study reinforces the urgency of implementing innovative methods to reduce airborne disease transmission and safeguard public health against emerging biological threats.

Indexed as

COVID-19AnimalsCricetinaeHumansMesocricetusPublic HealthRespiratory Aerosols and DropletsSARS-CoV-2airhamster modelhealthcareinactivationrespiratorySARS-CoV-2sterilizationtransmissionUV-C lightviruses

Identifiers

PMID38257789
PMCPMC10820972
OpenAlexW4390614579

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.